Uptake of shingles vaccination is more likely if proactively offered in primary care

The shingles vaccination programme is intended for people aged between 70 and 80 years, but uptake in this group has been low. This survey found that people were more likely to have had the vaccine if it was proactively offered by a GP or nurse.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news

Related Links:

Herpes zoster, otherwise known as shingles, can be a devastating complication after heart transplantation due to persistent and severe herpetic neuralgia. Our heart transplant patients are recommended to have the shingles vaccine prior to heart transplantation, but this is not always achieved. We sought to assess whether the shingles vaccine did indeed prevent clinical shingles development after heart transplantation.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: (1223) Source Type: research
ConclusionsTaken together, these results highlight that the gE subunit vaccine and LAV developed in this study can be functional VZV vaccines, and ssRNAs appear to function better as adjuvants in a subunit vaccine than in an LAV.
Source: Immunity, Inflammation and Disease - Category: Allergy & Immunology Authors: Tags: ORIGINAL RESEARCH Source Type: research
New evidence suggests the Zoster Vaccine Live — administered to prevent shingles — could also reduce the risk of stroke in older adults.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news
Title: Shingles Vaccine Bonus: Reduced Risk of Stroke?Category: Health NewsCreated: 2/12/2020 12:00:00 AMLast Editorial Review: 2/13/2020 12:00:00 AM
Source: MedicineNet Heart General - Category: Cardiology Source Type: news
WEDNESDAY, Feb. 12, 2020 -- Seniors who get the shingles vaccine may gain stroke protection as well, a new study suggests. Shingles is a viral infection tied to heightened risk of stroke. But overall stroke risk dropped 20% among patients under age...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Adults re-exposed to the herpes zoster virus found to be around 30% less likely to develop shingles Related items fromOnMedica GPs are dealing with growing flu rates Experts predict 'invigorated' winter flu Illness poorly managed in those with learning disability Flu activity appears to be nearing its peak Doctors can help overcome ‘vaccine hesitancy’
Source: OnMedica Latest News - Category: UK Health Source Type: news
(University of Tennessee Health Science Center) The College of Pharmacy at the University of Tennessee Health Science Center has partnered with Kroger Health, the healthcare arm of The Kroger Co., on a nationwide, randomized controlled study across more than 2,200 community pharmacy locations to improve second-dose vaccination completion rates for the shingles vaccine. Elements of the project are funded through a grant from GlaxoSmithKline.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
These reports provide an evaluation of the shingles vaccination programme in England from 2018 to 2019.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
The Advisory Committee on Immunization Practices (ACIP) recommends that adults aged ≥19 years receive various vaccines to prevent serious health conditions, including hepatitis B, herpes zoster/shingles, human papilloma virus (HPV), and pneumonia. Recent vaccine approvals by the US Food and Drug Administration (FDA) have led to updates in the ACIP adult immunization schedule. Thi s article provides a relevant clinical literature review for nurse practitioners on the newly approved vaccines for hepatitis B and herpes zoster and updated ACIP recommendations.
Source: The Journal for Nurse Practitioners - Category: Nursing Authors: Tags: Featured Article Source Type: research
Conclusions: Despite the availability and broad use of pertussis containing vaccines in the setting of pregnancy and infants, use of these vaccines in Australian adults remains limited. These findings highlight a significant opportunity to improve awareness and uptake of pertussis containing vaccines in individuals with chronic respiratory disease.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Respiratory infections Source Type: research
More News: Health | Nurses | Nursing | Primary Care | Shingles | Shingles (Herpes Zoster) Vaccine | Vaccines